资讯

Sanofi (NASDAQ:SNY) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 30, Sanofi (NASDAQ:SNY) announced that ...
Sanofi (NASDAQ:SNY) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 25, Sanofi (NASDAQ:SNY) ...
On June 25, Sanofi (NASDAQ:SNY) announced that the FDA granted orphan drug designation to Riliprubart for treating antibody-mediated rejection in solid organ transplantation.
The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.
Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...
与去年上半年情况不同,今年第二大主要布局领域为感染性疾病,共有 9 款生物药新药首次进入 III 期,来自辉瑞、万泰生物、华兰生物等企业。从成分类别来看,除预防性疫苗以外,还涉及非抗体类融合蛋白、单抗。 已顺利完成的 GC101-2 型 IND 项目 I/II 期临床试验数据表明,接受 GC101 注射液治疗的 2 型 SMA 受试者已观察到积极且显著的疗效,多名受试者获得了运动里程碑的突破。